PSCH Holdings Information

PSCH is an equity ETF with a total of 74 individual holdings. The top holdings are Glaukos stock at 4.87%, Protagonist Therapeutics at 4.74%, TG Therapeutics at 4.35%, Alkermes at 3.65%, and Ligand Pharmaceuticals at 3.18%.

Total Holdings

Top 10 Percentage

34.56%

Asset Class

Equity

ETF Category

Health

Assets

182.25M

PE Ratio

25.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GKOS	Glaukos Corporation	4.87%	57,332
2	PTGX	Protagonist Therapeutics, Inc.	4.74%	62,896
3	TGTX	TG Therapeutics, Inc.	4.35%	137,875
4	ALKS	Alkermes plc	3.65%	163,065
5	LGND	Ligand Pharmaceuticals Incorporated	3.18%	19,378
6	LQDA	Liquidia Corporation	2.81%	72,212
7	MMSI	Merit Medical Systems, Inc.	2.78%	58,037
8	PTCT	PTC Therapeutics, Inc.	2.77%	81,123
9	TFX	Teleflex Incorporated	2.71%	41,185
10	RDNT	RadNet, Inc.	2.69%	68,845
11	ITGR	Integer Holdings Corporation	2.29%	33,039
12	INDV	Indivior PLC	2.27%	114,709
13	ICUI	ICU Medical, Inc.	2.21%	24,307
14	CON	Concentra Group Holdings Parent, Inc.	2.19%	115,270
15	VCYT	Veracyte, Inc.	2.08%	78,140
16	AMRX	Amneal Pharmaceuticals, Inc.	1.95%	179,428
17	OGN	Organon & Co.	1.92%	255,254
18	ATRC	AtriCure, Inc.	1.65%	49,442
19	ARQT	Arcutis Biotherapeutics, Inc.	1.60%	111,176
20	NEOG	Neogen Corporation	1.59%	211,950
21	WAY	Waystar Holding Corp.	1.59%	117,418
22	LFST	LifeStance Health Group, Inc.	1.56%	241,382
23	TMDX	TransMedics Group, Inc.	1.55%	33,703
24	ACAD	Acadia Pharmaceuticals Inc.	1.53%	125,610
25	NHC	National HealthCare Corporation	1.50%	12,330

Showing 25 of 74 holdings

Subscribe to see the full list

Activate Now

As of Sep 24, 2026